Emphasizing on its capacity in remodeling insulin signaling and mitochondrial fitness, we examined the efficacy of TM5441 in decreasing hepatic steatosis, inflammation, and ultimately fibrosis, which are the hallmarks of NAFLD progression. The gene discussed is INS; the disease is fatty liver disease.